Skip to main content
SpringerLink
Log in

Cilnidipine Improves Insulin Sensitivity in the Otsuka Long-Evans Tokushima Fatty Rat, a Model of Spontaneous NIDDM

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Abstract

Summary. Among the antihypertensive drugs, fast-acting Ca2+ antagonists have been reported to worsen insulin sensitivity. This effect may be attributable to reflex increases in sympathetic activity. On the other hand, however, it has been reported that long-acting, dihydropiridine Ca2+ antagonists improve insulin-resistance. The purpose of this study was to investigate whether cilnidipine, another long-acting dihydropidine Ca2+ antagonist, improves insulin sensitivity in Otsuka Long-Evans Tokushima Fatty (OLETF) rat, a model of spontaneous NIDDM. 25 weeks OLETF rats were divided into the following groups; normal-diet group, cilnidipine-supplemented group (cilnidipine 3mg/kg/day) and angiotensin II receptor antagonist CS-866-supplemented group (CS-866 1mg/kg/day). As a non-diabetic control, we used Long-Evans-Tokushima-Otsuka rats (non-diabetic rats). Glucose infusion rate (GIR), an index of insulin resistance, as measured by the hyperinsulinemic euglycemic clamp technique was significantly decreased in OLETF rats. Cilnidipine-treatment partially but significantly improved insulin sensitivity in addition to systolic blood pressure in OLETF rats at 30 weeks of age, although it did not decrease accumulation of abdominal fat or serum levels of glucose or insulin. CS-866, an angiotensin 2 receptor antagonist, which lowers blood pressure through a different mechanism, did not improve insulin resistant states in OLETF rats. These results suggest that cilnidipine has a beneficial effect on insulin-resistance together with the antihypertensive effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z. Hyperinsulinemia, a link between hypertension, obesity and glucose intolerance. J Clin Invest 1985;75:809–817.

    Google Scholar 

  2. Haffner SM, Fong D, Hazuda HP, Pugh JA, Patterson JK. Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non diabetics. Metabolism 1988;37:338–345.

    Google Scholar 

  3. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595–1607.

    Google Scholar 

  4. Kaplan NM. The deadly quartet, Upper body obesity, glucose intolerance, hypertriglycemia, and hypertension. Arch Intern Med 1989;49:1514–1520.

    Google Scholar 

  5. DeFronzo RA, Ferrannini E. Insulin resistance A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173–194.

    Google Scholar 

  6. Berne C, Pollare T, Lithell H. Effects of antihypertensive treatment on insulin sensitivity with special reference to ACE inhibitors. Diabetes Care 1991;14:39–47.

    Google Scholar 

  7. Kodama J, Katayama S, Tanaka K, Itabashi A, Kawazu S, Ishii J. Effect of captopril on glucose concentration. Possible role of augmented postprandial forearm blood flow. Diabetes Care 1990;13:1109–1111.

    Google Scholar 

  8. Giordano M, Matsuda M, Sanders L, Canessa ML, DeFronzo RA. Effects of angiotensin converting enzyme inhibitors, Ca channel antagonists and a adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension. Diabetes 1995;44:665–671.

    Google Scholar 

  9. Sheu WH, Swislocki AL, Hoffman B, Chen YD, Reaven GM. Comparison of the effects of atenolol and nifedipine on glucose, insulin, and lipid metabolism in patients with hypertension. Am J Hypertens 1991;4:199–205.

    Google Scholar 

  10. Tomiyama H, Kushiro T, Abeta H, et al. Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor. Hypertension 1994;23:450–455.

    Google Scholar 

  11. Rosenthal T, Erlich Y, Rosenmann E, Cohen A. Effects of enalapril, losartan, and verapamil on blood pressure and glucose metabolism in the cohen-rosenthal diabetic hypertensive rat. Hypertension 1997;29:1260–1264.

    Google Scholar 

  12. Harano Y, Kageyama A, Hirose J, Asakura Y, Yokota T, Ikebuchi M, Suzuki M, Omae T. Improvement of insulin sensitivity for glucose metabolism with the long acting Ca channel blocker amlodipine in essential hypertensive subjects. Metabolism 1995;44:315–319.

    Google Scholar 

  13. Iimura O, Shimamoto K, Masuda A, Higashiura K, Miyazaki Y, Hirata A, Fukuoka M, Murakami H. Effects of a calcium channel blocker, manidipine, on insulin sensitivity in essential hypertensives. J Diab Comp 1995;9:215–219.

    Google Scholar 

  14. Kawano K, Hirashima T, Mori S, Natori T. OLETF (Otsukal Long Evans Tokushima Fatty) rat: A new NIDDM rat strain. Diabetes Res Clin Pract 1994;24 Suppl:S317–320.

    Google Scholar 

  15. Sakamoto S, Minami K, Niwa Y, Ohnaka M, Nakaya Y, Mizuno A, Kuwajima M, Shima K. Effect of exercise training and food restriction on endothelium dependent relaxation in the Otsuka Long Evans Tokushima Fatty rat, a model of spontaneous NIDDM. Diabetes 1998;47:82–86.

    Google Scholar 

  16. Ishida K, Mizuno A, Min Z, Sano T, Shima K. Which is the primary etiologic event of Otsuka Long Evans Tokushima Fatty rats, a model of spontaneous non insulin dependent diabetes mellitus, insulin resistance, or impaired insulin secretion? Metabolism 1995;44:940–945.

    Google Scholar 

  17. Rocchini AP. Insulin resistance and blood pressure regulation in obese and non-obese subjects. Hypertension 1991;17:837–842.

    Google Scholar 

  18. Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin: Direct measurement is vascular endothelial cells. J Clin Invest 1996;98:894–898.

    Google Scholar 

  19. Walker AB, Dores J, Buckingham RE, Savage MW, Williams G. Impaired insulin-induced attenuation of noradrenaline-mediated vasoconstriction in insulin-resistant obese Zucker rats. Clin Sci Colch 1997;93:235–241.

    Google Scholar 

  20. Draznin B. Cytosolic calcium and insulin resistance. Am J Kidney Dis 1993;21(6 Suppl 3):32–38.

    Google Scholar 

  21. Julius S, Jamerson K. Sympathetics, insulin resistance and coronary risk in hypertension, the “chicken and egg” question. J Hypertens 1994;12:495–502.

    Google Scholar 

  22. Pollare T, Lithell H, Selinus I, Berne C. Application of parzosin is associated with an increase of insulin sensitivity in obese patients with hypertension. Diabetologia 1988;31:415–420.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nutrition, School of Medicine, The University of Tokushima, Tokushima, Japan

    Nagakatsu Harada, Masaharu Onaka, Sadaichi Sakamoto, Yasuharu Niwa & Yutaka Nakaya

Authors
  1. Nagakatsu Harada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masaharu Onaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sadaichi Sakamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yasuharu Niwa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yutaka Nakaya
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harada, N., Onaka, M., Sakamoto, S. et al. Cilnidipine Improves Insulin Sensitivity in the Otsuka Long-Evans Tokushima Fatty Rat, a Model of Spontaneous NIDDM. Cardiovasc Drugs Ther 13, 519–523 (1999). https://doi.org/10.1023/A:1007827720807

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007827720807

Search

Navigation